The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organization (WHO) has issued new guidelines recommending the twice-yearly use of injectable lenacapavir ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorsement arrives amidst funding concerns, with Gilead ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

The WHO’s 2025 policy brief highlights how tuberculosis disproportionately affects marginalized and high-risk populations due ...

A new global report from the World Health Organization (WHO) Commission on Social Connection reveals that one in six people ...

Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...